Skip to content

A Randomized Controlled Trial of Three Non-pharmacologic Analgesic Techniques for Casting of Clubfoot Infants

A Randomized Controlled Trial of Three Non-pharmacologic Analgesic Techniques for Casting of Clubfoot Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02395185
Enrollment
33
Registered
2015-03-20
Start date
2013-01-31
Completion date
2014-10-31
Last updated
2017-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clubfoot

Brief summary

While it has been shown that sucrose or milk ingestion decreases pain responses in heel sticks, no study up to this point has determined the best intervention for decreasing the pain response during casting for clubfoot deformity. The goal of this study is to investigate the effect of three different non-pharmacologic interventions (sucrose, milk, water) on pain response during clubfoot casting. This study will allow us to discern the best non-pharmacologic intervention for pain control during clubfoot casting and to provide a more pleasant, comfortable experience for patients and families.

Detailed description

Clubfoot deformity in newborns is common, occurring in 1-2/1000 births. Treatment of this deformity has shifted from surgical to non-surgical management. The non-surgical management includes utilizing the Ponseti technique of manipulation and casting, followed by Achilles tenotomy and brace application. The newborn undergoes, on average, 4-6 casts before the foot deformity is corrected. During this manipulation and casting, the infants can become fussy and irritable. This irritability is likely due to discomfort felt from the manipulative process and subsequent casting. Studies that have focused on decreasing the pain response to heel sticks for laboratory testing in the neonatal intensive care units used sucrose or milk ingestion and swaddling in newborns to decrease pain responses. Both sucrose and milk have been shown to decrease the pain response as measured by the Premature Infant Pain Profile (PIPP) or the Bernese Pain Scale for Neonates. In addition, other pain scales have been used in newborn babies including the CRIES, CHIPPS, NIPS, and COMFORT scales to evaluate the effectiveness of pain relieving interventions. These scales were used alongside objective physiologic measurements such as heart rate, heart rate variability (HRV), respiratory rate, and oxygen saturation. While it has been shown that sucrose or milk ingestion decreases pain responses in heel sticks, no study up to this point has determined the best intervention for decreasing the pain response during casting for clubfoot deformity. The goal of this study is to investigate the effect of three different non-pharmacologic interventions (sucrose, milk, water) on pain response during clubfoot casting, allowing us to discern the best non-pharmacologic intervention for pain control during clubfoot casting and to provide a more pleasant, comfortable experience for patients and families. A secondary objective is to investigate whether or not family environment or the level of anxiety felt by the parents impacts the pain felt by the infant during the casting process.

Interventions

OTHERMilk bottle administration

Patients are given a bottle of milk during the casting process.

OTHERWater bottle administration

Patients are given a bottle of water during the casting process.

OTHERSucrose bottle administration

Patients are given a bottle of sucrose during the casting process.

Sponsors

Kosair Charities, Inc.
CollaboratorOTHER
University of Kentucky
CollaboratorOTHER
Shriners Hospitals for Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Days to 6 Months
Healthy volunteers
No

Inclusion criteria

* idiopathic clubfoot deformity * undergoing clubfoot casting for correction

Exclusion criteria

* cannot use a bottle for feeding * on solid food * have had surgery * have been given an analgesic within three hours prior to data collection

Design outcomes

Primary

MeasureTime frameDescription
NIPS (Neonatal Infant Pain Scale)Scoring will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting.Each cast visit will be videotaped before, during, and after casting, and later reviewed for subjective evaluation of pain using NIPS (Neonatal Infant Pain Scale). The NIPS examines six behavioral groupings that contribute to a pain score ranging from 0 to 7: facial expression (relaxed muscles or grimace), cry (no cry, whimper, or vigorous cry), breathing patterns (relaxed, change in breathing), arms (relaxed/restrained, flexed/extended), legs (relaxed/restrained, flexed/extended), state of arousal (sleeping/awake, fussy). Scoring will take place by a trained study personnel blinded to the contents of the bottle. Scoring for all measures will be recorded at minute intervals. A pre casting score from the average of the first 3 minute scores prior to casting; a during casting score from the average of the scores at 1 minute intervals during casting; and a post casting score from the average of the 3 minute scores post casting. Scores are categorized as 0 no pain, to \>4 severe pain.

Secondary

MeasureTime frameDescription
Heart RateHeart rate will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting.Heart rate will be recorded at minute intervals. A pre casting measure from the average of the first 3 minute measures prior to casting; a during casting measure from the average of the measures at 1 minute intervals during casting; and a post casting measure from the average of the 3 minute measures post casting.
Oxygen SaturationOxygen saturation will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post castingOxygen saturation will be recorded at minute intervals. A pre casting measure from the average of the first 3 minute measures prior to casting; a during casting measure from the average of the measures at 1 minute intervals during casting; and a post casting measure from the average of the 3 minute measures post casting.

Participant flow

Recruitment details

53 participants were assessed for eligability. 33 patient participants and their guardians were enrolled in the study from 3/13/13 to 9/17/14 at their initial clinical visit. A total of 131 casts were performed.

Participants by arm

ArmCount
All Participants
Bottle Administration: 2 oz of sucrose, water, or milk/formula given in a bottle during the casting process Bottle Administration: Patients are given a bottle during the casting process. Contents of bottle depend on the arm to which they are randomized.
33
Total33

Baseline characteristics

CharacteristicAll Participants
Age, Continuous17.9 days
STANDARD_DEVIATION 20.5
Age, Customized
<=18 years
33 participants
Age, Customized
>=65 years
0 participants
Age, Customized
Between 18 and 65 years
0 participants
Region of Enrollment
United States
33 participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
24 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
1 / 290 / 260 / 26
serious
Total, serious adverse events
0 / 290 / 260 / 26

Outcome results

Primary

NIPS (Neonatal Infant Pain Scale)

Each cast visit will be videotaped before, during, and after casting, and later reviewed for subjective evaluation of pain using NIPS (Neonatal Infant Pain Scale). The NIPS examines six behavioral groupings that contribute to a pain score ranging from 0 to 7: facial expression (relaxed muscles or grimace), cry (no cry, whimper, or vigorous cry), breathing patterns (relaxed, change in breathing), arms (relaxed/restrained, flexed/extended), legs (relaxed/restrained, flexed/extended), state of arousal (sleeping/awake, fussy). Scoring will take place by a trained study personnel blinded to the contents of the bottle. Scoring for all measures will be recorded at minute intervals. A pre casting score from the average of the first 3 minute scores prior to casting; a during casting score from the average of the scores at 1 minute intervals during casting; and a post casting score from the average of the 3 minute scores post casting. Scores are categorized as 0 no pain, to \>4 severe pain.

Time frame: Scoring will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting.

Population: Because this was a crossover design, multiple casts were assessed for each participant

ArmMeasureGroupValue (MEAN)Dispersion
MilkNIPS (Neonatal Infant Pain Scale)NIPS post casting2.11 units on a scaleStandard Deviation 2.37
MilkNIPS (Neonatal Infant Pain Scale)NIPS casting0.91 units on a scaleStandard Deviation 1.26
MilkNIPS (Neonatal Infant Pain Scale)NIPS pre casting2.28 units on a scaleStandard Deviation 2.38
WaterNIPS (Neonatal Infant Pain Scale)NIPS pre casting1.63 units on a scaleStandard Deviation 2.12
WaterNIPS (Neonatal Infant Pain Scale)NIPS casting2.22 units on a scaleStandard Deviation 2.01
WaterNIPS (Neonatal Infant Pain Scale)NIPS post casting1.49 units on a scaleStandard Deviation 2.29
SucroseNIPS (Neonatal Infant Pain Scale)NIPS pre casting1.84 units on a scaleStandard Deviation 2.18
SucroseNIPS (Neonatal Infant Pain Scale)NIPS post casting0.69 units on a scaleStandard Deviation 1.53
SucroseNIPS (Neonatal Infant Pain Scale)NIPS casting0.63 units on a scaleStandard Deviation 1.27
Secondary

Heart Rate

Heart rate will be recorded at minute intervals. A pre casting measure from the average of the first 3 minute measures prior to casting; a during casting measure from the average of the measures at 1 minute intervals during casting; and a post casting measure from the average of the 3 minute measures post casting.

Time frame: Heart rate will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting.

Population: Because this was a crossover design, multiple casts were assessed for each participant

ArmMeasureGroupValue (MEAN)Dispersion
MilkHeart Ratecasting152.54 bpmStandard Deviation 12.87
MilkHeart Ratepre casting152.72 bpmStandard Deviation 20.45
MilkHeart Ratepost casting147.2 bpmStandard Deviation 12.05
WaterHeart Ratecasting152.59 bpmStandard Deviation 9.03
WaterHeart Ratepre casting145.69 bpmStandard Deviation 17.12
WaterHeart Ratepost casting143.89 bpmStandard Deviation 13.06
SucroseHeart Ratepre casting155.9 bpmStandard Deviation 15.71
SucroseHeart Ratepost casting149.78 bpmStandard Deviation 12.99
SucroseHeart Ratecasting154.33 bpmStandard Deviation 24.55
Secondary

Oxygen Saturation

Oxygen saturation will be recorded at minute intervals. A pre casting measure from the average of the first 3 minute measures prior to casting; a during casting measure from the average of the measures at 1 minute intervals during casting; and a post casting measure from the average of the 3 minute measures post casting.

Time frame: Oxygen saturation will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting

Population: Because this was a crossover design, multiple casts were assessed for each participant

ArmMeasureGroupValue (MEAN)Dispersion
MilkOxygen Saturationpost casting98.07 percentage of SpO2Standard Deviation 2.07
MilkOxygen Saturationcasting97.38 percentage of SpO2Standard Deviation 1.26
MilkOxygen Saturationpre casting98 percentage of SpO2Standard Deviation 1.57
WaterOxygen Saturationpost casting97.85 percentage of SpO2Standard Deviation 2.34
WaterOxygen Saturationpre casting97.52 percentage of SpO2Standard Deviation 2.26
WaterOxygen Saturationcasting97.56 percentage of SpO2Standard Deviation 3.23
SucroseOxygen Saturationcasting94.32 percentage of SpO2Standard Deviation 12.43
SucroseOxygen Saturationpre casting98.33 percentage of SpO2Standard Deviation 1.63
SucroseOxygen Saturationpost casting98.18 percentage of SpO2Standard Deviation 1.62

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026